Naveen Pemmaraju, MD; MD Anderson Cancer Center #BtC_ASCO21
14:58
Dr. Naveen Pemmaraju discusses Using and Sequencing JAK Inhibitors for Patients with Myelofibrosis.
Dr. Naveen Pemmaraju discusses Using and Sequencing JAK Inhibitors for Patients with Myelofibrosis.
Beyond the Congress: ASCO21 Similar Videos
-
Matthew Davids, MD, MMSc; Dana-Farber Cancer Inst. #BtC_ASCO21
15:27
Dr. Matthew Davids reviews Recently Presented Data of Clinical Trials and Standard of Care in Upfront Treatment for CLL.
-
Maria-Victoria Mateos, MD, PhD; University of Salamanca #BtC_ASCO21
13:10
Dr. Maria-Victoria Mateos discusses Recently Presented Data of Clinical Trials and Standard of Care in Relapsed/Refractory MM
-
Alison J. Moskowitz, MD; Memorial Sloan Kettering Cancer Center #BtC_ASCO21
16:28
Dr. Alison Moskowitz presents on Treatments for Upfront and Relapsed Hodgkin’s Lymphoma.